Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2009
06/04/2009US20090142310 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
06/04/2009CA2742926A1 Pd-1 modulation and uses thereof
06/04/2009CA2707157A1 Microrna expression profiling and targeting in peripheral blood in lung cancer
06/03/2009EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization
06/03/2009EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2064347A2 Methods for the identification, evaluation and treatment of patients having cc-chemokine receptor 2(ccr-2) mediated disorders
06/03/2009EP2064336A2 Interleukin -13 binding proteins
06/03/2009EP2064328A2 Sensitization of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
06/03/2009EP2064226A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators
06/03/2009EP2064224A2 Tissue culture system for production of hepatitis c virus
06/03/2009EP2063709A2 Hindered ester-based biodegradable linkers for oligonucleotide delivery
06/03/2009EP1859039A4 Compositions and method for storage of nucleic acid from bodily fluids
06/03/2009EP1638983A4 Switchable nucleic acids for diagnostics, screening and molecular electronics
06/03/2009EP1565714A4 Uncaging devices
06/03/2009CN101448849A Compositions and methods for inhibiting expression of Eg5 gene
06/03/2009CN101448848A Ras mutation and compositions and mehods related thereto
06/03/2009CN101448847A Oligonucleotides affecting expression of phosphodiesterases
06/03/2009CN101445540A Use of survivin gene targeted siRNA in preparing medicine capable of regulating and controlling tumour cell cycle
06/03/2009CN101445539A Use of high efficiency siRNA for preparing drug capable of adjusting and controlling tumor cell cycle
06/03/2009CN101445538A Use of high efficiency siRNA for preparing drug capable of adjusting and controlling tumor cell cycle
06/03/2009CN101445537A New use of gene targeted small interfering RNA for preparing tumor migration inhibition drug
06/03/2009CN101445536A New use of high efficiency gene targeted siRNA for preparing tumor migration inhibition drug
06/03/2009CN101445535A Use of siRNA for preparing tumor migration inhibition drug
06/03/2009CN101445534A Use of high efficiency siRNA for preparing tumor migration inhibition drug
06/03/2009CN101445533A Nucleic acid extracting reagent as well as preparation method and usage thereof
06/03/2009CN100494380C A nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its fragment and application
06/03/2009CN100494215C Structure of siRNA for target survivin gene and antineoplastic use
06/03/2009CN100494214C Small interference RNA sequence of hepatitis B virus gene and preparation method thereof
06/03/2009CN100494213C Process for preparing synergistic factor in artificial blood, nucleotide sequence used thereby
06/02/2009US7541491 Gene involved in growth-promoting function of acetic acid bacteria and uses thereof
06/02/2009US7541455 Microwave mediated synthesis of nucleic acid probes
06/02/2009US7541454 Compounds and methods for fluorescent labeling
06/02/2009US7541453 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response
06/02/2009US7541452 Monocotyledon promoter sequences for use as tools to enhance heterologous gene expression in plants
06/02/2009US7541451 Nucleotide sequences coding green fluorescent proteinfor use as reporter molecules in gene expression and polypeptide analysis
06/02/2009US7541450 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
06/02/2009US7541448 Oligonucleotides containing molecular rods
06/02/2009US7541447 Nucleotide sequence of the pgm gene of a Brucella bacterium modified by a partial or complete deletion of the sequence coding for phosphoglucomutase; live vaccine for immunization, prophylaxis or treatment of brucellosis comprises such a bacterium, either lyophilized or in a pharmaceutical vehicle
06/02/2009US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
06/02/2009US7541444 Invention relates to nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, and which molecules may be used in reactions where blocked nucleotide or nucleoside molecules are required, such as in sequencing reactions, polynucleotide synthesis
06/02/2009US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it
06/02/2009US7541436 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus
06/02/2009US7541435 Antagonists of cxcr3-binding cxc chemokines
06/02/2009US7541344 Modulation of survivin expression
06/02/2009US7541314 Microarray having a base cleavable sulfonyl linker
06/02/2009US7541193 Caged sensors, regulators and compounds and uses thereof
06/02/2009US7541181 Vector carrying a polynucleotide which encodes a GSD polypeptide from Mycobacterium paratuberculosis
06/02/2009US7541180 comprising administering to a cells or tissues in vitro; hepatitis C virus (HCV) antigens; dna immunization
06/02/2009US7541172 DNA sequence encoding a polypeptide having the biological activity of amorpha-4,11-diene synthase, which is used to produce the specific precursor in the synthesis of artemisinin
06/02/2009US7541171 Halohydrin dehalogenases and related polynucleotides
06/02/2009US7541169 nucleotide sequence variant and nucleotides flanking the sequence; used for determining if a mammal is predisposed to thyroid disease or cancer
06/02/2009US7541168 Recombinant cyclopentanone monooxygenase [cpmo]
06/02/2009US7541163 Expression vector comprising nucleotide sequences coding multifunctional protein with viricidal activity
06/02/2009US7541148 A primer for analyzing gene mutation having a primer binding sequence 1 and 2 and, a restriction enzyme recognition sequence wherein single stranded polynucleotide fragments of 2-32 bases are produced by amplifying with the primer and cleaved by the restriction enzymes; medical diagnosis; accuracy
06/02/2009US7541146 Biomolecule retaining material and methods for attaching biomolecules to a surface
06/02/2009US7541142 Protein useful for diagnosis, cancer therapy
06/02/2009US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
06/02/2009CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
05/2009
05/28/2009WO2009067647A1 Carbocyclic alpha-l-bicyclic nucleic acid analogs
05/28/2009WO2009067644A1 Compositions, systems and methods for obtaining and expanding insulin-producing cells
05/28/2009WO2009067177A2 Bone morphogenic protein binding peptide
05/28/2009WO2009066642A1 Photoresponsive base having triazole skeleton
05/28/2009WO2009046141A3 Antisense modulation of fibroblast growth factor receptor 4 expression
05/28/2009WO2009039862A3 Enzymatic incorporation of lna nucleotides
05/28/2009WO2009038841A3 Portable, temperature and chemically inducible expression vector for high cell density expression of heterologous genes in escherichia coli
05/28/2009WO2008140478A4 Compositions and methods for immunodominant antigens
05/28/2009WO2008043426A3 Components and method for enzymatic synthesis of nucleic acids
05/28/2009WO2007058704A3 Compositions and methods for detection of colorectal cancer
05/28/2009US20090138992 Limnanthes oil genes
05/28/2009US20090138991 Plants having improved growth characteristics and method for making the same
05/28/2009US20090138989 Methods and Compositions for Selecting Corn Plants Resistant to Diplodia Ear Rot
05/28/2009US20090138986 Regulatory Elements Associated with CBF Transcription Factors of Maize
05/28/2009US20090138984 Genes involved in tolerance to environmental stress
05/28/2009US20090138977 Pancreatic cancer targets and uses thereof
05/28/2009US20090137791 solid phase synthesis of oligonucleotides and peptides on silicon chips, multiwell plates, glass beads
05/28/2009US20090137790 Method of capping oligonucleic acid
05/28/2009US20090137789 Oligonucleotide Probes
05/28/2009US20090137788 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection
05/28/2009US20090137787 Janus family kinases and identification of immune modulators
05/28/2009US20090137677 Abuse-resistant amphetamine prodrugs
05/28/2009US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression
05/28/2009US20090137519 represents phosphodiester or phosphodiester-like internucleotide linkage; for treating allergy, such as allergic rhinitis and asthma, cancer and hepatitis B and hepatitis C infectious diseases
05/28/2009US20090137518 Therapeutic Antiangiogenic Endostatin Compositions
05/28/2009US20090137515 Abuse-resistant amphetamine prodrugs
05/28/2009US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/28/2009US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases
05/28/2009US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137510 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
05/28/2009US20090137507 RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/28/2009US20090137506 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/28/2009US20090137505 Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same
05/28/2009US20090137504 Microrna target site blocking oligos and uses thereof
05/28/2009US20090137500 Chemically synthesized doubled stranded micro-RNA (miRNA) molecule; nucleic acids with a pyrimidine modification
05/28/2009US20090137472 Chimeric mhc protein and oligomer thereof
05/28/2009US20090137470 Methods of treating cancer using notch pathway inhibitors
05/28/2009US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection
05/28/2009US20090137413 Manipulation of Microparticles In Microfluidic Systems